Cargando…
Evolution of core archetypal phenotypes in progressive high grade serous ovarian cancer
The evolution of resistance in high-grade serous ovarian cancer (HGSOC) cells following chemotherapy is only partially understood. To understand the selection of factors driving heterogeneity before and through adaptation to treatment, we profile single-cell RNA-sequencing (scRNA-seq) transcriptomes...
Autores principales: | Nath, Aritro, Cosgrove, Patrick A., Mirsafian, Hoda, Christie, Elizabeth L., Pflieger, Lance, Copeland, Benjamin, Majumdar, Sumana, Cristea, Mihaela C., Han, Ernest S., Lee, Stephen J., Wang, Edward W., Fereday, Sian, Traficante, Nadia, Salgia, Ravi, Werner, Theresa, Cohen, Adam L., Moos, Philip, Chang, Jeffrey T., Bowtell, David D. L., Bild, Andrea H. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8144406/ https://www.ncbi.nlm.nih.gov/pubmed/34031395 http://dx.doi.org/10.1038/s41467-021-23171-3 |
Ejemplares similares
-
Exploiting collateral sensitivity controls growth of mixed culture of sensitive and resistant cells and decreases selection for resistant cells in a cell line model
por: Grolmusz, Vince Kornél, et al.
Publicado: (2020) -
Multiple ABCB1 transcriptional fusions in drug resistant high-grade serous ovarian and breast cancer
por: Christie, Elizabeth L., et al.
Publicado: (2019) -
A `one-two punch' therapy strategy to target chemoresistance in estrogen receptor positive breast cancer
por: Chi, Feng, et al.
Publicado: (2020) -
Predicting clinical response to everolimus in ER+ breast cancers using machine-learning
por: Nath, Aritro, et al.
Publicado: (2022) -
ENDORSE: a prognostic model for endocrine therapy in estrogen‐receptor‐positive breast cancers
por: Nath, Aritro, et al.
Publicado: (2022)